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Abstract
Background—Corticotropin releasing hormone (CRH) and urocortins (UCNs) bind to 
corticotropin releasing hormone type 2 receptor (CRH-R2), a Gs protein-coupled receptor that 
plays an important role in modulation of anxiety and stress responses. The Crhr2 gene maps to a 
quantitative trait locus (QTL) for alcohol preference on chromosome 4 previously identified in 
inbred alcohol-preferring (iP) and non-preferring (iNP) F2 rats.
Methods and Results—Crhr2 mRNA expression was determined in male alcohol-naïve iP and 
iNP rats in several brain regions, and lower levels of Crhr2 mRNA were observed in iP rats 
compared to iNP rats. To identify genetic variation that may underlie differences detected in 
Crhr2 expression, DNA sequencing was performed and variations were identified in the promoter 
region, coding region and 3’-untranslated region between the iP and iNP rats. A 7bp insertion in 
the Crhr2 promoter of iP rats altered expression in vitro as measured by reporter assays. While 
CRH-R2 binding affinity did not significantly differ between male iP and iNP receptor variants, 
CRH-R2 density was lower in the amygdala of iP as compared to iNP rats. Male P rats displayed 
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decreased social interaction and significantly higher corticosterone levels directly following 30 
minute restraint when compared to male NP rats.
Conclusions—This study identified Crhr2 as a candidate gene of interest underlying the 
chromosome 4 QTL for alcohol consumption that was previously identified in the P and NP 
model. Crhr2 promoter polymorphism reduced mRNA expression in certain brain regions, 
particularly the amygdala, and lowered the density of CRH-R2 in the amygdala of iP compared to 
iNP rats. Together, these differences between the animals may contribute to the drinking disparity 
as well as the anxiety differences of the P and NP animals.
Keywords
Alcoholism; corticotropin releasing hormone type 2 receptor; Selective breeding; Stress; 
Amygdala
INTRODUCTION
The selectively bred alcohol-preferring (P) and –nonpreferring (NP) rats have been 
established as an animal model of alcoholism displaying the necessary phenotypic criteria 
(Cicero, 1979). Utilizing quantitative trait locus (QTL) analysis, a previous study identified 
a highly significant QTL (LOD = 9.2) for alcohol consumption and alcohol preference on 
chromosome 4 in a population of iP X iNP F2 rats (Bice et al., 1998; Carr et al., 1998). This 
QTL was later confirmed utilizing congenic strains that were derived from the iP and iNP 
lines (Carr et al., 2006). Crhr2 has been identified as a potential candidate gene of interest 
due to its role in alcohol drinking behavior (Ryabinin et al., 2012) and because it maps to the 
peak of the chromosome 4 QTL region (83.8 Mbp).
CRF1 and CRF2 receptors are Gs-coupled 7-transmembrane receptors. Numerous studies 
have shown that binding of corticotropin-releasing hormone (CRF) to the type 1 receptor 
(CRF1 receptor) plays an important role in the regulation of the adaptive response to stress 
as well as alcohol drinking (Greetfeld et al., 2009; Heilig and Koob, 2007). However, only 
limited research has studied the role of CRF2 receptor in the regulation of alcohol drinking 
in rodents. CRF2 receptor is involved in excessive dependent-like ethanol drinking in rats 
(Funk and Koob, 2007). Additionally, Crhr2 knockout mice exhibit increased alcohol 
drinking when utilizing a limited-access procedure (Sharpe et al., 2005), and the 
administration of a CRF2 receptor agonist reverses the increases in ethanol self-
administration during the early stages of ethanol withdrawal in rats (Valdez et al., 2004).
In addition to CRF itself, the CRF family consists of urocortin 1 (coded by UCN I), 
urocortin 2 (UCN II), and urocortin 3 (UCN III), as well as CRF-binding protein (Ryabinin 
et al., 2002). These ligands differ in their distribution within the central nervous system 
(CNS) as well as their receptor pharmacology. For example, CRF binds to CRF1 receptor 
with high affinity, whereas Urocortin 1 binds with high affinity to both CRF1 receptor and 
CRF2 receptor (Lovenberg et al., 1995). Unlike CRF and Urocortin 1, Urocortin 2 and 
Urocortin 3 appear to be selective for CRF2 receptor (Chen et al., 2005; Inoue et al., 2003; 
Lewis et al., 2001). The infusion of UCN 3, a CRF2 receptor agonist, into the central 
amygdala has been shown to decrease ethanol self-administration in alcohol-dependent 
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Wistar rats (Funk and Koob, 2007). Both Ucn1 KO mice and Crhr2 KO mice showed a lack 
of ethanol-induced conditioned placed preference compared to WT littermates indicating 
that Urocortin 1 acting on CRF2 receptor may be a mechanism for alcohol preference 
(Giardino et al., 2011). Interestingly, inbred P (iP) rats have significantly lower levels of 
Urocortin 1 than iNP rats in the centrally-projecting Edinger-Westphal nucleus (EWcp) 
where Urocortin 1 is primarily expressed (Turek et al., 2005).
The CRF and CRF1 receptor system is involved in activating the HPA axis and regulating 
emotional and cognitive function after stress (Arborelius et al., 1999; Todorovic et al., 
2005). However, the involvement of urocortins and the CRF2 receptor system involvement 
is just emerging (Chen et al., 2005; Kageyama et al., 2003; Valdez et al., 2004). While CRF1 
receptors are distributed throughout the brain, the tissue distribution of the CRF2 receptor is 
more restricted to specific brain regions (Van Pett et al., 2000). Studies utilizing Crhr2 
knockout mice suggest that CRF2 receptor may dampen or modulate responses to stress 
associated with CRF1 receptor activation (Bale and Vale, 2004). Together, these receptors 
are thought to maintain the homeostasis of stress responses with CRF1 receptor activation 
yielding an anxiogenic response and CRF2 receptor activation playing an anxiolytic role 
(Greetfeld et al., 2009; Valdez et al., 2004).
P rats are more “anxious” than NP rats (Pandey et al., 2005; Stewart et al., 1993), and P rats 
show a greater stress-induced increase in alcohol drinking than NP rats (Chester et al., 
2004b). Both acoustic startle and fear potentiated startle responses are consistently greater in 
P than NP rats (Chester et al., 2004a; McKinzie et al., 2000). P and NP strains exhibited 
both neurobiological and neurochemical differences in CRH (Murphy et al., 2002). For 
example, CRH levels were lower in the amygdala, hypothalamus, prefrontal cortex, and 
cingulate cortex in P rats compared to NP rats, (Ehlers et al., 1992), particularly in the 
central nucleus of the amygdala (Hwang et al., 2004).
The purpose of this study was to screen for functional variation in the Crhr2 gene, and then 
further characterize the variations in the P and NP lines. Quantitative real-time PCR (qRT-
PCR) was conducted to measure Crhr2 mRNA expression in iP and iNP rats, and DNA 
sequence analysis used to screen for polymorphisms in the Crhr2 promoter and transcript 
between the iP and iNP lines. Luciferase assays and binding studies were performed to 
determine the functional significance of identified polymorphisms. To examine potential 
consequences of Crhr2 polymorphism on behavioral and endocrine responses associated 
with environmental stress, corticosterone levels and social interaction (SI) were assessed 
before and after 30 minutes of restraint.
MATERIALS AND METHODS
Experimental animal care
The experimental protocol used in this study was reviewed and approved by the Indiana 
University Institutional Animal Care and Use Committee and was carried out in accordance 
with the Guide for the Care and Use of Laboratory Animals. All rats were housed under 
twelve hour light–dark conditions (7:00 am / 7:00 pm) with free access to food and water. 
To avoid confounding results due to gender, only males were used for this research.
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Molecular characterization of iP versus iNP rats
Dissection of brain regions—The entire brain was removed from alcohol-naïve adult 
male iP (n=5) and iNP (n=4) rats and dissected using the coordinates of Paxinos and Watson 
(Paxinos, 1998) to isolate seven brain regions including the (1) nucleus accumbens, (2) 
frontal cortex, (3) amygdala, (4) septum, (5) hippocampus, (6) caudate-putamen and (7) 
hypothalamus. These brain regions were selected due to their involvement in the regulation 
of the reinforcing properties of alcohol, the motor and memory impairing effects of alcohol, 
and the adaptation to stress (McBride and Li, 1998). The detailed methods of the dissections 
were previously published (Bice et al., 2008; Liang et al., 2004). All equipment used to 
dissect the tissues was treated with RNase Zap (Ambion, Austin, TX) to prevent RNA 
degradation.
mRNA expression analysis—The microdissected tissues were snap frozen on dry ice 
and stored at -80°C until RNA isolation. RNA was isolated according to the RNeasy Midi 
manufacturer’s protocol (Qiagen, Valencia, CA). The isolated RNA was then treated with 
DNase I. Using the ABI PRISM 7700 (Life Technology, Foster City, CA), the relative 
mRNA expression levels of Crhr2 were determined in the dissected brain regions. Vector 
NTI (Invitrogen, Carlsbad, CA) was utilized to design primer (LC551 and LC552, Table 1). 
For the qRT-PCR assay, cDNA was generated from the RNA each sample obtained from iP 
and iNP rats using 50 ng of total RNA template, 0.2 μM forward and reverse primers, and 
SYBR Green PCR Master Mix (Life Technology). Amplification was performed in triplicate 
for 40 cycles in two separate experiments resulting in six values for each sample. The 
specificity of the PCR product was confirmed using gel electrophoresis.
The relative values of expression were determined using the standard curve method, and 
normalized to the Ct values of “housekeeping” gene cyclophillin B, (LC555 and LC556, 
Table 1). No differences were detected in the average cyclophilin B Ct values when 
comparing iP versus iNP in each respective brain region, indicating that cyclophilin B 
represents an appropriate control for normalization. Repeated measurement ANOVA was 
used and statistical significance was set at p<0.05.
DNA sequence analysis—Genomic DNA isolated from male iP and iNP rats was used 
to sequence the promoter regions using four primers (LC730 to LC733, Table 1). Primers 
were designed based on the Crhr2 1.5 kb promoter region sequence accessed from the 
Ensembl Genome Browser (accession # ENSRNOG00000011145). Next, total RNA was 
isolated from male iP (n=4) and iNP (n=4) rats, pooled, and reverse transcribed to generate 
cDNA (RETROscript kit; Ambion). Based on the rat Crhr2 cDNA sequence (NM_022714; 
U16253), four primer pairs were designed: LC530 to LC537 (Table 1). These primers were 
utilized to amplify four overlapping DNA fragments that encompassed the entire rat Crhr2 
cDNA sequence. The PCR products were purified (GenElute PCR Cleanup Kit, Sigma, St. 
Louis, MO) and subsequently sequenced (Thermo Sequenase Cycle Sequencing Kit, USB, 
Cleveland, OH).
Transient transfection and dual-luciferase activity assays—The reporter plasmids 
utilized in this study were constructed as previously described (Liang et al., 2003). Briefly, 
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the promoter regions of the iP and iNP animals were generated and spanned from -1396 to 
-214 (Ref Seq NM_022714). These DNA fragments were fused upstream of the luciferase 
gene in the pGL3-basic vector to test the promoter polymorphism function. In addition, 3’-
UTR fragments were generated from the iP and iNP lines from +1452 to +1626 relative to 
the translational start site (+1) to measure the effects of polymorphism on 3’UTR function. 
For transient transfections, human neuroblastoma SK-N-SH cells were cultured and 
transfected as previously described (Liang et al., 2003). Using Tfx-50 reagent (Promega, 
Madison, WI), 0.5 μg of the pGL-3 luciferase plasmids were co-transfected along with 4 ng 
of CMV Renilla luciferase vector (pRL-CMV) per well. The pRL-CMV was utilized as an 
internal control for transfection efficiency. The resulting cell extracts were assayed for 
firefly and Renilla luciferase activities in a TD-20/20 Luminometer using the Dual-
Luciferase Reporter Assay System. The reporter assays were performed five times in 
triplicate using plasmids that were independently purified at least twice.
CRF2 receptor binding studies
Characterization of CRF2 receptor binding affinity in membrane homogenates
—The conditions that were utilized for receptor binding assays were performed as 
previously described (Grigoriadis et al., 1996; Rominger et al., 1998). Frozen brain tissues 
dissected from the frontal cortex of iP (n=8) and iNP (n=8) rats were homogenized in assay 
buffer (50 mM Tris HCL, 2 mM EGTA, 10 mM MgCL2, pH 7.2). Typically, 50 mg of brain 
wet tissue was homogenized in a 1 ml assay buffer, and then incubated for 30 minutes in a 
37°C water bath to degrade endogenous CRH. The assay buffer was enriched with 0.1% 
BSA, 0.1% zinc-free Bacitracin and 100 KU/ml aprotinin, and all displacers and radioactive 
ligand solutions were diluted in enriched buffer. Each assay was initiated by adding 50 μl of 
membrane suspension (~250 μg protein) to 150 μl of enriched buffer containing [125I]-Tyr0-
sauvagine (PerkinElmer, Inc., Boston, MA) and 50 μl of the displacer Astressin 2B, a 
selective CRF2 receptor antagonist (Tocris Bioscience, Ellisville, MI) or a non-specific 
binding peptide. The final concentration of radioactive ligand was 0.175 nM and non-
specific binding was determined in the presence of 1 μM of CRH (American Peptide 
Company, Sunnyvale, CA). Astressin 2B was then used to determine inhibition profiles at 
the following final concentrations: 0.1, 0.3, 1.0, 3.0, 10.0, 30.0, 100, or 1000 nM. Binding 
assays were performed in duplicate. Tubes were incubated at ambient temperature for 2 hrs 
and were added to 0.5 ml of ice-cold enriched assay buffer containing 0.01 % Triton X-100 
(wash buffer) followed by centrifuging at 4°C for 5 minutes at 12,000 × g. Aspiration of 
buffer followed by washing and aspiration. Separation of bound from free radioligand 
occurred during the centrifugation, and the bottom 0.75 cm of each tube containing the 
pellet was cut with a microtube cutter into 12 × 75 mm test tubes for counting in a gamma 
counter (ICN, Huntsville, AL) at 80% efficiency. Graph Pad Prism Version 4 software was 
used to generate the competition profile of Astressin 2B.
Autoradiagraphic determination of CRF2 receptor binding density—Sections 
from selected brain regions were prepared from each iP (n=10) and iNP rat (n=10) that were 
sacrificed at 12-13 weeks of age using decapitation. The brains were rapidly removed and 
flash frozen in a pre-cooled isopentane solution on dry ice and stored at -70°C until 
sectioned. Autoradiography was performed as previously described (Sanchez et al., 1999). 
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Briefly, tissue sections were pre-incubated twice for 10 minutes in 50 mM Tris-HCl (pH 
7.4) containing 10 mM MgCl2 and 2 mM EGTA. The sections were then incubated for 2 
hours at room temperature with 200 pM [125I]-Tyr0-sauvagine in the above solution with 
0.1% bovine serum albumin (BSA), aprotinin (0.04 TIU/ml), and 0.1 mM bacitracin. Two 
sets of adjacent sections were used for the detection of CRF1 receptor and CRF2 receptor, 
respectively. Specific CRF1 receptor binding was determined using 200 pM [125I]-Tyr0-
sauvagine in the presence of 1uM Astressin 2B, and specific CRF2 receptor binding was 
determined in the presence of 1 uM Stressin I (Tocris Bioscience, Ellisville, MI), a specific 
CRF1 receptor agonist. Non-specific binding was determined with [125I]-Tyr0-sauvagine in 
the presence of 1 uM unlabeled sauvagine due to its high affinity for both CRF1 receptor and 
CRF2 receptor (Grigoriadis et al., 1996; Primus et al., 1997). Following a 90 minute 
incubation at room temperature, all sections were washed twice in PBS (pH 7.4) that 
contained 1% BSA and in deionized water at 4°C. Brain slices were air dried, placed in 
cassettes with [125I]-Microscale slides (American Radiolabeled Chemicals, Inc., St. Louis, 
MO), and were exposed to BAS-TR2025 imaging plates overnight. The imaging plates were 
scanned using a BAS5000 system. Digital images were generated from the Phosphor 
imager, and were analyzed using Multi Gauge software (V2.3) where the brain regions of 
interest were defined by anatomical landmarks as described in the atlas of Paxinos (Paxinos, 
1998). Microscale standards were used as quantitative reference points for analysis.
Characterization of the stress response in selectively bred P and NP rats
The selectively bred P and NP lines (n=8 per group) were used for the stress response study 
because the iNP rats display a severe bleeding problem due to the absence of platelet 
aggregation making implantation of arterial catheters very difficult (Smith et al., 1996). 
Notably, the coding and promoter sequence differences between iP and iNP also exist in the 
selectively bred P and NP rats. Age-matched, adult Wistar rats (Harlan, Indianapolis, IN) 
that had no previous contact with the “test” rats were used as partner rats for the social 
behavior tests.
Stress response protocol—A restraint stress response protocol was conducted to 
measure the effect(s) of 30 minute restraint on plasma corticosterone levels and social 
interaction. Six time points (30 minute intervals) were measured during two sessions. 
During the first session (no restraint), blood samples were drawn for measurement of plasma 
corticosterone at baseline 1 (T0), baseline 2 (T1), 30 (T2), 60 (T3), 90 (T4) and 120 (T5) 
minutes after exposure to a novel male rat during the social interaction test. During the 
second session (30 minute restraint), blood samples were drawn for measurement of plasma 
corticosterone at baseline (T6), 30 (T7), 60 (T8), 90 (T9), 120 (T10) and 150 (T11) minutes 
after 30 minutes of restraint (see Figure 6). The social interaction test was conducted 
immediately following the second blood draw during both sessions (at 30 minutes), and the 
P and NP rats were restrained for 30 minutes immediately following the first blood draw 
(T6) during the second testing session. All experiments were conducted in the morning 
during the light phase of the light/dark cycle between 8:00 AM and 11:30 AM.
Plasma corticosterone measurements—At approximately fourteen weeks of age 
(350-450 g), P and NP rats were individually housed. Arterial catheters were then inserted in 
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anesthetized rats into the femoral artery, filled with heparinized saline (25 U/ml), and routed 
subcutaneously to the dorsal midline of the neck where they were fixed using a leather 
jacket. Arterial catheters were flushed daily with heparinized saline to prevent clotting. 
Blood samples were drawn via the arterial catheter. Samples were immediately placed on 
dry ice in tubes. Plasma was then isolated from each sample by centrifugation and stored at 
-80°C. Plasma corticosterone levels were assayed using the ImmuChem Double Antibody 
Corticosterone 125I RIA kit (MP Biomedicals, Orangeburg, NY), and the inter- and intra-
assay coefficients of variation were less than 7% and 10%, respectively. To test time and 
strain interactions, we first utilized the data points from T1 to T5 with T0 as baseline, and 
then used the data points from T7 to T11 with T6 as baseline. Plasma corticosterone level 
data was analyzed using a repeated measure ANOVA, and post-hoc analysis was performed 
at each specific time point. Statistical significance was set at p<0.05.
Social interaction test—The social interaction (SI) test was performed to characterize 
the social response to stress. This test of anxiety has been repeatedly shown to be highly 
sensitive to the effects of CRH or other neuropeptides in the CNS (Gehlert et al., 2005; 
Rainnie et al., 2004). Before conducting the SI tests, the P and NP rats were singly housed 
for one week and handled daily. Prior to the SI test, the rats were placed into the SI 
apparatus for a 5 minute habituation session and were exposed to the test room for at least 
30 minutes. A modified SI test was used to measure SI. In this test, the experimental P and 
NP rats were placed in an open field (0.9 m long × 0.9 m wide with walls 0.3 m high) with a 
novel male Wistar rat. During the five minute test, the total amount of time the experimental 
rats (i.e., P or NP) initiated interaction with the partner Wistar rat was recorded as described 
previously (Shekhar and Keim, 1997). The primary behaviors that are measured in this test 
are social approach behaviors (nose-pokes, grooming, mutual exploration, etc.) that are 
specifically initiated by the experimental animal towards the partner animal during the 5 
minute observation period. All tests were videotaped and independently scored at a later 
time by two individuals who were unaware of the animals’ genotype using cumulative 
stopwatches. Between each session, the apparatus was cleaned with 70% ethanol. A repeated 
ANOVA was performed to test genotype and time interaction. Statistical significance was 
set at p<0.05.
RESULTS
Crhr2 mRNA levels are lower in discrete brain regions of alcohol-naïve iP rats compared to 
iNP rats
To assess the endogenous Crhr2 mRNA expression between iP and iNP rats, discrete brain 
regions dissected from alcohol-naïve iP and iNP rats were analyzed using qRT-PCR. Crhr2 
mRNA expression was observed at significantly lower levels in the hypothalamus 
(p=0.0329), amygdala (p=0.0001), and caudate putamen (p=0.0157) in the iP rats compared 
to iNP rats (Fig.1). No significant difference was observed in the nucleus accumbens 
(p=0.8911), frontal cortex (p=0.327), hippocampus (p=0.1108), or septum (p=0.5057).
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Polymorphism in the Crhr2 promoter, coding region, and 3’UTR between the iP and iNP 
rats
When 1.5 kb of promoter region was sequenced, a 7bp repeat insertion was identified in the 
iP sequence compared to the iNP sequence (Fig. 2). In addition, the Crhr2 cDNA, which 
included 215 bp of the 5’-UTR, the coding region, and 276 bp of the 3’UTR was sequenced 
in each strain, and a single nucleotide polymorphism (SNP) was observed in the coding 
region (Fig. 2). For iP rats, DNA sequencing detected a guanine (G) at nt +492, while the 
iNP sequence had an adenine (A) at this position. The iNP sequence at this position is 
identical to the published DNA sequence for rat (NM_022714). This coding alteration 
translates into an isoleucine to valine (Ile93Val) substitution in the extra cellular N-terminal 
domain (ECD1) of CRF2 receptor. Therefore, this polymorphism could potentially alter 
ligand binding affinity. In the 3’UTR, DNA sequencing revealed a deletion of a G at nt 1559 
in iP compared to iNP and the published DNA sequences (NM_022714) (Fig. 2). These 
same polymorphisms are also present and homozygous in the P and NP rat lines.
Crhr2 promoter polymorphism in iP rats decreased luciferase reporter gene expression
The functional relevance of the 7 bp insertion in the iP Crhr2 promoter was determined 
using luciferase assays (Fig. 3A). The transiently transfected pGL3-P luciferase reporter 
construct expressed lower luciferase activity than the pGL3-NP construct (Fig. 3A). The 
potential difference in transcription factor binding due to the 7 bp insertion was determined 
using Genomatix software (Fig. 3B). Three transcription factors were predicted including 
C2H2 Zinc finger transcription factors (C2H2 ZF), cAMP Response Element Binding 
Protein (CREB) and Pax3 (the paired box gene 3) (Fig. 3B). Transiently transfected 
luciferase reporter constructs that contained either the iP or iNP 3’UTR polymorphic Crhr2 
fragments did not produce statistically significant differences in luciferase expression (data 
not shown).
The Ile93Val substitution does not affect CRF2 receptor binding affinity
To determine whether the polymorphism identified in the coding region at 492 bp influenced 
receptor binding affinity, a competitive homogenate binding experiment was performed 
using Astressin 2B, a selective CRF2 receptor antagonist (Fig. 4). The IC50 for a series of 
assays using frontal cortex membrane homogenate was 0.77 nM and 0.71 nM for iP and iNP 
rats, respectively. Therefore, this SNP does not appear to result in altered receptor binding 
affinity between the two strains.
The polymorphism in the Crhr2 promoter is associated with altered binding density
To determine whether CRF2 or CRF1 receptor binding differences exist between the iP and 
iNP strains, in situ (Fig 5, A and B), autoradiography binding was performed using Astressin 
2B (a selective CRF2 receptor antagonist) or Stressin I (a specific CRF1 receptor agonist) as 
displacers. No statistically significant difference was observed in CRF1 receptor binding 
(Fig. 5C). However, a statistically significant decrease in CRF2 receptor binding was 
observed in the amygdala of iP relative to iNP rats (Fig. 5D). Non-specific binding was 
demonstrated in Fig. 5E. Quantification of binding density in the amygdala showed lower 
density of CRF2 receptor in iP relative to iNP (p<0.01, Fig. 5). No statistically significant 
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binding differences were detected between iP and iNP in the frontal cortex or nucleus 
accumbens (Fig. 5, bottom panel).
Differences in plasma corticosterone levels and social interaction following 30 minute 
restraint stress
In order to characterize the potential effects of Crhr2 polymorphism on HPA activation in 
the P and NP strains, corticosterone levels were measured before and after 30 minute 
restraint stress. No statistically significant differences were observed in basal corticosterone 
levels (T0-T1) between P and NP rats. Repeated measure ANOVA was used to test for any 
strain and time interactions of corticosterone levels, and no statistically significant 
interaction was observed from T1 to T5 (P=0.06, Fig. 6). However, a statistically significant 
time by genotype interaction was observed following 30 minutes of restraint stress from T7 
to T11 (p=0.035, Fig. 6). Data was analyzed by subtracting baseline at T6. Increases in 
corticosterone were also observed preceding the application of restraint stress in P relative to 
NP rats. Post-hoc analysis at each time point indicated statistically significantly higher 
corticosterone levels at T3, T6, and T7 in P compared to NP rats.
In order to determine the behavioral effects of Crhr2 polymorphism following 
environmental stress in the P and NP strains, social interaction (SI) was measured before and 
after 30 minute restraint stress. While no statistically significant differences were observed 
in SI between P and NP rats at basal levels (p=0.34), both the P and NP rats displayed 
decreases in SI following 30 minute restraint (Fig. 7). The P rats showed a modest, but 
statistically significant decrease in SI following 30 minute restraint compared to NP rats 
(p=0.008; Fig. 7). ANOVA analyses indicated significant SI differences before and after 30 
minute restraint in both the P and NP rats (p<0.0001), and no statistically significant 
interaction was observed between genotypes (p=0.65).
DISCUSSION
This study was conducted to characterize Crhr2 as a candidate gene of interest underlying 
the chromosome 4 QTL identified in iP and iNP rats and to examine its potential behavioral 
and endocrine consequences. First, mRNA studies detected statistically significantly lower 
Crhr2 transcript levels in three of seven brain regions of the iP strain compared to the iNP 
strain, and the same trend was observed in two other brain regions (Fig.1). Next, DNA 
sequence found polymorphism in the coding region (Ile93Val), promoter, and 3’UTR of the 
Crhr2 gene between the iP and iNP lines. Significant functional differences were associated 
with the promoter polymorphism in that the iP constructs showed lower transcriptional 
activity than the iNP. No significant differences were found for the 3’UTR polymorphism. 
CRF2 receptor binding affinity ex vivo was not altered by the Ile93Val. However, binding 
density was lower in the amygdala of iP rats compared to iNP rats, consistent with the 
mRNA expression data. Observed behavioral and physiological effects were associated with 
this variation in CRF2 receptor in that P rats displayed decreased social interaction and 
significantly higher corticosterone levels following 30 minute restraint compared to NP rats.
The polymorphism detected at nt +495 (amino acid 93) is located in the extracellular N-
terminal domain of the receptor where ligand binding was observed in the CRF1 receptor 
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(Dautzenberg et al., 1999). However, the Ile93Val substitution does not alter ligand binding 
affinity. In contrast, decreased CRF2 receptor density was detected in the amygdala of iP 
compared to iNP, which is consistent with lower CRF2 receptor expression in our in vitro 
reporter data. Our findings suggest that the differences in expression between the two 
sequence variants are preferentially present within amygdala neurons and likely driven by 
transcription factors or combinations of such factors.
Using Genomatix transcription factor binding sites analysis software, binding sites were 
found for C2H2 Zinc fingers, CREB, and Pax3 (Fig. 3D). Notably, the distance between 
C2H2 ZF transcription factor and CREB binding sites is increased due to the repeated 7bp 
(AGATCGT) insert in the iP rat, and this increase may potentially account for the difference 
in expression between the iP and iNP strains.
Evidence suggests that the CRF1 receptor and CRF2 receptor may work in concert to 
regulate alcohol drinking behavior (Bale et al., 2002; Sommer et al., 2008). Binge-like 
ethanol intake of C57BL/6J mice is modulated by CRF1 receptor and CRF2 receptor 
signaling, such that blockade of CRF1 receptor or activation of CRF2 receptor effectively 
reduces excessive ethanol intake (Lowery et al., 2010). Furthermore, upregulation of Crhr1 
and down regulation of Crhr2 mRNA expression was observed in the basolateral amygdala 
of rats following a history of dependence when compared to alcohol naive animals (Sommer 
et al., 2008). Interestingly, the present study found that iP rats expressed lower levels of 
Crhr2, and unpublished data obtained by Dr. Liang also indicated higher levels of Crhr1 in 
multiple brain regions including the amygdala when compared to iNP rats. Higher Crhr1 
mRNA expression in P rats is consistent with innate up-regulation of the Crhr1 transcript in 
several limbic brain areas of high alcohol preferring msP rats (Hansson et al., 2006). 
Previous studies found that both brain region injection of CRF can promote drinking and 
administration of CRF1 receptor antagonists prevented increased drinking in P rats (Gilpin et 
al., 2008; Knapp et al., 2011). Thus, lower levels of CRF2 receptor and higher levels of 
CRF1 receptor may play an important role in excessive drinking seen in P rats.
Other studies also suggest that Crhr2 is implicated in the modulation of alcohol 
consumption, anxiety, and the adaptive response to stress. For instance, Crhr2 knockout 
mice display increases in anxiety-like behavior (Bale and Vale, 2004), which is consistent 
with lower expression of Crhr2 and higher in anxiety seen in iP compared to iNP rats 
(Stewart et al., 2004). Another study found that CRH over-expression was associated with 
up-regulation of Crhr2 mRNA and down regulation of Crhr1 mRNA (Korosi et al., 2006). 
Thus, a positive correlation between CRF and Crhr2 mRNA, but a negative relationship 
between CRF and Crhr1 mRNA were previously observed (Ehlers et al., 1992).
CRF2 receptor system is involved in anxiety and the adaptive response to stress (Joels and 
Baram, 2009; Ryabinin et al., 2012). Experimental manipulations that lead to increased 
anxiety are associated with decreased SI (Sajdyk et al., 2006). In our studies, SI was 
associated with an increase in corticosterone levels in the P and NP animals with the P rats 
exhibiting higher levels than the NP rats (Fig. 6). In addition, 30 minutes of restraint stress 
resulted in significantly higher levels of corticosterone in P rats relative to NP rats, and 
Yong et al. Page 10
Alcohol Clin Exp Res. Author manuscript; available in PMC 2015 May 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
larger decrease in social interaction time in P than NP rats (Fig. 7) which is consistent with 
previous observation (File and Seth, 2003).
The urocortin system, particularly the centrally-projecting Edinger-Westphal (EWcp) nuclei, 
could influence alcohol drinking. (EWcp)-Ucn1 neurons have been shown to play a role in 
EtOH drinking as well as reward (Giardino et al., 2011). iNP rats show significantly higher 
levels of UCN 1 than iP rats in the EWcp (Turek et al., 2005), and lower Ucn2 mRNA 
expression levels in than iP in multiple brain regions (Liang, unpublished). We speculate 
that promoter polymorphism in Crhr2 regulates its gene expression, and may likely lead to 
alteration of expression of Crhr1, CRH and Urocortins. The difference in alcohol drinking 
and anxiety is due to changes in expression for some of these genes; however, we speculate 
that the primary reason for these differences in drinking is due to the difference in CRF2 
receptor expression. We understand that other interactions between CRF and NPY systems 
are possible (Sajdyk et al., 2006).
Together, these data provide novel information regarding how selective breeding for alcohol 
drinking has contributed to a divergence in multiple systems involved in the regulation of 
both alcohol consumption and the adaptive response of the CNS to environmental stressors. 
Ultimately, the CRF2 receptor may provide an interesting target for the treatment of 
alcoholism related to anxiety.
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Figure 1. Crhr2 mRNA expression differences
qRT-PCR was utilized to compare the relative levels of Crhr2 expression between iP and 
iNP in various brain regions. The graph depicts the mean ± SEM of the results from two 
independent experiments performed in triplicate. Significant differences in regional Crhr2 
were determined using ANOVA. Asterisks denote a significant difference in mRNA 
expression (*p<0.05, ** p=0.0001).
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Figure 2. Crhr2 DNA polymorphism in iP rats as compared to iNP rats
A schematic gene structure delineating the polymorphisms identified in the promoter region, 
coding region, and 3’UTR region of rat Crhr2. The magnified panel depicts the DNA 
sequence differences detected in Crhr2 in iP relative to iNP rats including a 7bp insertion in 
the promoter, a coding mutation at +492 (iNPA/iPG), and an +1559 G deletion in the 3’UTR. 
The coding mutation identified in iP rats results in an Ile/Val amino acid substitution.
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Figure 3. Relative Luciferase activity associated with Crhr2 promoter polymorphism
(A) Three pGL-3 promoter plasmids (pGL3-P, pGL3-NP and pGL3 basic) were transfected 
into SK-N-SH cells to determine whether the Crhr2 promoter polymorphism affects 
luciferase gene expression. The relative expression of the luciferase gene from each 
construct is depicted as the mean ± SEM. ANOVA was used to detect significant differences 
in mean values within and between multiple constructs (p<0.05). (B) Using Genomatix 
software, the predicted transcription factor binding sites included CREB, C2H2, and Pax3.
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Figure 4. CRF2 receptor binding in alcohol-naïve iP and iNP rats
Characterization of CRF2 receptor binding was determined by [125I]-Tyr0-sauvagine affinity 
in frontal cortex homogenates from naïve iP and iNP rats. The graph depicts the competition 
profile in the presence of increasing concentrations of Astressin 2B. Each data point 
represents the mean ± SEM of eight separate experiments performed in duplicate.
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Figure 5. CRF2 receptor density in alcohol-naïve iP and iNP rats
(A) Cresyl violet stained sections indicate that the amygdala sections shown are from the 
anterior portion of the amygdala. (B) The schematic diagram illustrates the corresponding 
brain section and localizes the region of interest with a circle. (C) Representative 
autoradiogram of total [125I]-Tyr0-sauvagine binding which includes CRF1 receptor and 
CRF2 receptor binding. (D) Representative section showing specific CRF2 receptor binding 
determined by [125I]-Tyr0-sauvagine binding in the presence of 1 μM of Stressin 1 (a 
specific CRF1 receptor agonist). (E) Nonspecific binding determined by [125I]-Tyr0-
sauvagine binding in the presence of 1 μM of unlabeled sauvagine. The bar graph depicts the 
density of CRF2 receptor binding in the amygdala (AMYG), pre-frontal cortex (PFC), and 
nucleus accumbens (NAc). The asterisk indicates a significant difference between the 
groups (**p<0.01). No significant difference was found in the CRF1 receptor density (bar 
graph not included).
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Figure 6. Differences in corticosterone levels between P and NP rat lines
Corticosterone levels were determined at each time point (T0 – T11) with 30 minutes 
between the time intervals. The time at T0 and T6 was 8:00 AM. The SI test was performed 
immediately following the 2nd blood draw each day (T1 and T7). Restraint stress was for 30 
minutes from T6 – T7. Following 30 minute restraint stress, a significant time by genotype 
interaction was observed from T7 to T11 (p=0.035). Asterisk denotes significant differences 
between P and NP rats at specific time points (*p<0.05).
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Figure 7. Social interaction time differences between P and NP rat lines
The social interaction test was performed on the selectively bred P and NP rats before and 
after 30 minute restraint stress. The SI time (seconds) is the total amount of interaction time 
(sniffing, grooming, etc.) initiated between the P or NP rat and a Wistar rat. Asterisk denotes 
significant differences between P and NP rats and between restraint and no restraint 
(*p<0.05, ** p<0.0001).
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Table 1
List of primers
Crhr2 sequencing primers
 Transcript sequencing
 LC530 CCCTCATCTCCGTGA
 LC531 GTGAGTAGTTGATCCTTGAG
 LC532 GCATCAAGTACAACACGACC
 LC533 TGGAGTACGTCATGACGATG
 LC534 TCACCAACTTCTTCTGGATG
 LC535 CTGAAAGGACTGCAGGAAAG
 LC536 GTCACAGATTGTGTTCATCTAC
 lc537 CCTGGTCTTTCAGAGCCTC
 LC537 GAGGCTCTGAAAGACCAGG
 Promoter sequencing
 LC730-rCrhr2PrSF AGCCCTGCTTAAGCCAG
 LC731-rCrhr2PrSR TATCCTGGGCACCAGATAGAGTGAGAG
 LC732-rCrhr2PrF TCATGCTCAGACCTAAGACTGCCG
 LC733-rCrhr2PrR GCCTGCTCGACCATGACCAATAG
qRT-PCR primers
 lc551-crhr2-f CTGCAGTCCTTTCAGGGTTTCTTTG
 lc552-crhr2-r CAACGGTGCCACCGCTTTCT
 lc555-cyc-f AAAGACACCAATGGCTCCCAGTTC
 lc556-cyc-r GTACCACATCCATGCCTTCCAGAAC
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